BLD-2660

· Blade Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BLD-2660, covering 2022-04-06 to 2022-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects [Phase 2]